3 reports

  • It include eight countries of the Europe: France, Germany, Italy, Sweden, Switzerland, Russia, Poland and United Kingdom
  • It include eight countries of the Europe: France, Germany, Italy, Sweden, Switzerland, Russia, Poland and United Kingdom

Europe Proton Therapy Market has a market potential of much more than US$ 10 Billion in 2016. In the year 2009 France used be have the highest proton therapy market share. But by 2012 Germany replaced France from the top position and it continues to hold its top position in 2016 as well. According to Renub Research study by the year 2019 Germany...

  • Cancer
  • Europe
  • Northern Europe
  • Poland
  • Western Europe
  • 7.2 Growing Incidence of Cancer Patients
  • POLAND - FORECAST FOR NUMBER OF PATIENT DIAGNOSED WITH CANCER (NUMBER), 2017 - 2022

Proton Therapy is one of the most technologically advanced treatments for cancer. With an increasing incidence of cancer, there is a definite need for novel, cutting edge, treatment methods, such as, Proton Therapy. Unfortunately, the access to proton therapy is limited for a vast population, owing to a low number of proton therapy...

  • Cancer
  • Diagnostic Imaging
  • Poland
  • Market Size
  • Felicitex Therapeutics Enters into Co-Development Agreement with Selvita
  • H3 Biomedicine Extends Agreement with Selvita

Felicitex' s target therapy areas comprise colorectal cancer, pancreatic cancer, non-small cell lung cancer and ovarian cancer.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Poland